Previous Articles Next Articles
FU Jinyu1, LIN Jinguan1,2
[1] Sutton A J and Higgins J P T, Recent development in meta-analysis, Statistics in Medicine, 2008, 27(5): 625–650. [2] Hozo S P, Djulbegovic B, and Hozo I, Estimating the mean and variance from the median, range, and the size of a sample, BMC Medical Research Methodology, 2005, 5(1): 13. [3] Wan X, Wang W, Liu J, et al., Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range, BMC Medical Research Methodology, 2014, 14(1): 135–135. [4] Luo D, Wan X, Liu J, et al., Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range, Statistical Methods in Medical Research, 2018, 27(6): 1785–1805. [5] DerSimonian R and Laird N, Meta-analysis in clinical trials, Controlled Clinical Trials, 1986, 7(3): 177–188. [6] Senn S, Trying to be precise about vagueness, Statistics in Medicine, 2007, 26(7): 1417–1430. [7] Verhagen A P, de Vet H C W, de Bie R A, et al., The art of quality assessment of RCTs included in systematic reviews, Journal of Clinical Epidemiology, 2001, 54(7): 651–654. [8] Berard A and Bravo G, Combining studies using effect sizes and quality scores: Application to bone loss in postmenopausal women, Journal of Clinical Epidemiology, 1998, 51(10): 801–807. [9] Tritchler D L, Modelling study quality in meta-analysis, Statistics in Medicine, 1999, 18(16): 2135–2145. [10] Fleiss J L and Gross A J, Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique, Journal of Clinical Epidemiology, 1991, 44(2): 127–139. [11] Shadish W R and Haddock C K, Combining estimates of effect size, Eds. by Cooper H, Hedges L V, and Valentine J C, The handbook of research synthesis and meta-analysis (p.257 C277). Russell Sage Foundation, 2009. [12] Doi S A R and Thalib L, A quality-effects model for meta-analysis, Epidemiology, 2008, 19(1): 94–100. [13] Doi S A R, Barendregt J J, and Mozurkewich E L, Meta-analysis of heterogeneous clinical trials: An empirical example, Contemporary Clinical Trials, 2011, 32(2): 288–298. [14] Doi S A R, Barendregt J J, Khan S, et al., Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model, Contemporary Clinical Trials, 2015, 45: 123–129. [15] Doi S A R, Barendregt J J, Khan S, et al., Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model, Contemporary Clinical Trials, 2015, 45: 130–138. [16] Greenland S and O’Rourke K, On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions, Biostatistics, 2001, 2(4): 463–471. [17] Ahn S and Becker B J, Incorporating quality scores in meta-analysis, Journal of Educational and Behavioral Statistics, 2011, 36(5): 555–585. [18] Lee K J and Thompson S G, Flexible parametric models for random-effects distributions, Statistics in Medicine, 2008, 27(3): 418–434. [19] Arellano-Valle R B, Bolfarine H, and Lachos V H, Skew-normal linear mixed models, Journal of Data Science, 2005, 3(4): 415–438. [20] Lin T I and Lee J C, Estimation and prediction in linear mixed models with skew-normal random effects for longitudinal data, Statistics in Medicine, 2008, 27(9): 1490–1507. [21] Wu M, Zhao J, Wang T, et al., The ANOVA-type inference in linear mixed model with skewnormal error, Journal of Systems Science and Complexity, 2017, 30(3): 710–720. [22] Macgillivray H L, Skewness and asymmetry: Measures and orderings, The Annals of Statistics, 1986, 14(3): 994–1011. [23] Wen F and Yang X, Skewness of return distribution and coefficient of risk premium, Journal of Systems Science and Complexity, 2009, 22(3): 360–371. [24] Bailey K R, Inter-study differences: How should they influence the interpretation and analysis of results? Statistics in Medicine, 1987, 6(3): 351–358. [25] Turner R M, Spiegelhalter D J, Smith G C S, et al., Bias modelling in evidence synthesis, Journal of the Royal Statistical Society: Series A (Statistics in Society), 2009, 172(1): 21–47. [26] Thompson S, Ekelund U, Jebb S, et al., A proposed method of bias adjustment for meta-analyses of published observational studies, International Journal of Epidemiology, 2010, 40(3): 765–777. [27] Spiegelhalter D J and Best N G, Bayesian approaches to multiple sources of evidence and uncertainty in complex cost effectiveness modelling, Statistics in Medicine, 2003, 22: 3687–3709. [28] Doi S A R, Evidence synthesis for medical decision making and the appropriate use of quality scores, Clinical Medicine & Research, 2014, 12(1–2): 40–46. [29] Kulinskaya E and Olkin I, An overdispersion model in meta-analysis, Statistical Modelling, 2014, 14(1): 49–76. [30] Pewsey A, Problems of inference for Azzalini’s skewnormal distribution, Journal of Applied Statistics, 2000, 27(7): 859–870. [31] Bayes C L and Branco E, Bayesian inference for the skewness parameter of the scalar skew-normal distribution, Brazilian Journal of Probability and Statistics, 2007, 21(2): 141–163. [32] Gelman A, Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper), Bayesian Analysis, 2006, 1(3): 515–534. [33] Doi S A R, Woodhouse N J, Thalib L, et al., Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: A meta-analysis revisited, Clinical Medicine and Research, 2007, 5(2): 87–90. [34] Higgins P T and Green S, Cochrane Handbook for Systematic Reviews of Interventions, John Wiley and Sons, New Jersey, 2011. [35] Arellano-Valle R B, Gmez, Hctor W, and Quintana F A, A new class of skew-normal distributions, Communications in Statistics — Theory and Methods, 2004, 33(7): 1465–1480. [36] Azzalini A, A class of distributions which includes the normal ones, Scandinavian Journal of Statistics, 1985, 12(2): 171–178. [37] Henze N, A probabilistic representation of the skew-normal distribution, Scandinavian Journal of Statistics, 1986, 13(4): 271–275. [38] Gupta R C and Brown N, Reliability studies of the skew-normal distribution and its application to a strength-stress model, Communications in Statistics — Theory and Methods, 2001, 30(11): 2427–2445. |
[1] | WANG Hongxia, ZHAO Zihan, WU Yuehua, LUO Xuehong. B-Spline Method for Spatio-Temporal Inverse Model [J]. Journal of Systems Science and Complexity, 2022, 35(6): 2336-2360. |
[2] | KATAHIRA Kei, CHEN Yu. Heterogeneous Round-Trip Trading and the Emergence of Volatility Clustering in Speculation Game [J]. Journal of Systems Science and Complexity, 2022, 35(1): 221-244. |
[3] | Atsunori KANEMURA;Shin-ichi MAEDA;Wataru FUKUDA;Shin ISHII. BAYESIAN IMAGE SUPERRESOLUTION AND HIDDEN VARIABLE MODELING [J]. Journal of Systems Science and Complexity, 2010, 23(1): 116-136. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||